Cargando...

Strategic priorities for respiratory syncytial virus (RSV) vaccine development

Although RSV has been a high priority for vaccine development, efforts to develop a safe and effective vaccine have yet to lead to a licensed product. Clinical and epidemiologic features of RSV disease suggest there are at least 4 distinct target populations for vaccines, the RSV naïve young infant,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anderson, L.J., Dormitzer, P.R., Nokes, D.J., Rappuoli, R., Roca, A., Graham, B.S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Science 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3919153/
https://ncbi.nlm.nih.gov/pubmed/23598484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.11.106
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!